Physician
Bajaj, Francesca
Bajaj, Francesca was paid $130K by Medicaid between Jan 2018 and Mar 2023, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoBAJAJ, FRANCESCA
WILBRAHAM, MA 01095
WILBRAHAM, MA 01095
33aNPI1639165517assigned 09/26/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$130K
24GClaims4,649
24DCodes billed17
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Massachusetts
Rank by total paid#26 of 54
Median peer was paid$119K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 776 | $28K | |
| 2019 | 884 | $26K | |
| 2020 | 611 | $16K | |
| 2021 | 830 | $22K | |
| 2022 | 1,476 | $36K | |
| 2023 | 72 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 805 | 783 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 249 | 241 | $24K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 15% | 504 | 502 | $19K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 7.4% | 1,038 | 1,038 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.6% | 143 | 143 | $7K |
| 96127 | 5.3% | 561 | 526 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4.6% | 437 | 432 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.3% | 128 | 128 | $3K |
| 99173 | 2.2% | 129 | 129 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 65 | 65 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | 12 | $1K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 12 | 12 | $994.32 |
5 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.